Tacere Therapeutics, a San Jose biotech start-up has raised seed financing to develop treatments for serious infectious diseases.
The financing came from from Hokkaido Venture Capital.
The company is developing a drug called “TT-033i,” for the treatment of Hepatitis C (HCV). See details here.
Trackback URL
